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Abstract
Bordetella pertussis is the causative agent of pertussis, aka whooping cough.
Although generally considered an extracellular pathogen, this bacterium has been
found inside respiratory epithelial cells, which might represent a survival strategy
inside the host. Relatively little is known, however, about the mechanism of
internalization and the fate of B. pertussis inside the epithelia. We show here that
B. pertussis is able to enter those cells by a mechanism dependent on microtubule
assembly, lipid raft integrity, and the activation of a tyrosine-kinase-mediated
signaling. Once inside the cell, a significant proportion of the intracellular bacteria
evade phagolysosomal fusion and remain viable in nonacidic lysosome-associated
membrane-protein-1-negative compartments. In addition, intracellular B. pertussis
was found able to repopulate the extracellular environment after complete
elimination of the extracellular bacteria with polymyxin B. Taken together, these
data suggest that B. pertussis is able to survive within respiratory epithelial cells
and by this means potentially contribute to host immune system evasion.
Introduction
Bordetella pertussis is a strictly human pathogen and the
main causative agent of whooping cough, aka pertussis.
Despite a high vaccination cover, pertussis remains
endemic within the world population. The persistence of
pertussis in countries with highly vaccinated populations has
been attributed to various causes including suboptimal
vaccines, a waning immunity, and pathogen adaptation
(He & Mertsola, 2008; Berbers et al., 2009; Mooi et al.,
2013). Bordetella pertussis colonizes the mucosa of the
respiratory tract, where the bacterium interacts with
epithelial cells and local immune surveillance cells. Although
certain potential contributors to colonization have been
described (de Gouw et al., 2011), the mechanisms that
allow this pathogen to evade immune clearance, causing a
highly contagious and prolonged respiratory disease, are
still under investigation.
Although B. pertussis is usually regarded as a noninva-
sive pathogen, a number of studies suggest that the
bacterium is able to enter into and eventually survive inside
the cells (Higgs et al., 2012). Bordetella pertussis have been
found within pulmonary alveolar macrophages from infants
and children with confirmed B. pertussis pneumonia
(Paddock et al., 2008) and inside alveolar macrophages of
HIV-infected children (Bromberg et al., 1991). Animal
infection models and studies using human monocytes in
culture have indicated that B. pertussis can enter and
survive inside those cells (Friedman et al., 1992; Hellwig
et al., 1999; Vandebriel et al., 2003). We recently found that
B. pertussis not only is able to survive inside human
macrophages, but also replicates in nonacidic compart-
ments having the characteristics of early endosomes
(Lamberti et al., 2010). These data suggest that the
pathogen has evolved mechanisms to evade phagolyso-
some fusion and survive intracellularly, so as to eventually
increase the opportunity of spreading to new hosts.
In the present study, we investigated whether B. pertussis
is also able to reside within epithelial respiratory cells and
proliferate from there. Previous studies in culture revealed
the presence of B. pertussis inside epithelial cells (Bassinet
et al., 2000; Ishibashi et al., 2001; Gueirard et al., 2005).
Moreover, B. pertussis has been found inside ciliated
respiratory epithelial cells in children with pneumonia
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(Paddock et al., 2008). Nevertheless, the ability of this
pathogen to enter, to survive, and replicate within human
respiratory epithelial cells remains to be conclusively
demonstrated.
Previous studies from our group showed that lipid raft
domains play a significant role in B. pertussis interaction
with epithelial cells and that filamentous hemagglutinin
(FHA) plays a critical role in this process (Lamberti et al.,
2009). Lipid rafts are defined as small, heterogeneous,
highly dynamic, sterol- and sphingolipid-enriched domains
that compartmentalize cellular processes (Pike, 2006).
Upon certain stimuli, such as protein–ligand binding, small
rafts coalesce into larger signaling platforms enabling the
assembly of a variety of signaling molecules within mem-
brane rafts, including molecules playing essential roles in
cytoskeletal reorganization (Hartlova et al., 2010). A wide
variety of pathogens – including viruses, bacteria, protozo-
ans, and prions – target molecules in host cell membrane
rafts to hijack host intracellular trafficking pathways and
invade host cells (Hartlova et al., 2010). In the example of
B. pertussis, the role of lipid rafts in the invasion process
has still not been studied, but previous reports have
indicated that FHA was involved in the entry of B. pertussis
into epithelial cells (Ewanowich et al., 1989; Bassinet et al.,
2000; Ishibashi et al., 2001), thus suggesting a connection
between FHA interaction with lipid rafts and bacterial
internalization. The present study aimed at elucidating the
mechanisms underlying the entry of B. pertussis into
epithelial respiratory cells and assessing the ability of the
bacteria to survive intracellularly.
Materials and methods
Bacterial strain and growth conditions
Bordetella pertussis strain B213, a streptomycin-resistant
derivative of Tohama I, was used in this study. In some
experiments, B213 transformed with plasmid pCW505
(Weingart et al., 1999; kindly supplied by Dr Alison Weiss,
Cincinnati, OH) – which induces cytoplasmic expression of
green fluorescent protein (GFP) without affecting growth or
antigen expression (Weingart et al., 1999) – was used.
Bacteria were stored at 70 °C and recovered by growth on
Bordet Gengou agar (BGA) plates supplemented with 15%
(v/v) defibrinated sheep blood (bBGA) at 35 °C for 3 days.
Virulent bacteria were subsequently plated on bBGA,
cultured for 20 h at 35 °C, and thereafter used in infection
assays.
Antibodies
The following antibodies were used: mouse monoclonal
antibody against human lysosome-associated membrane
protein 1 (LAMP1; BD Biosciences Pharmingen, San Diego,
CA), FITC-conjugated mouse monoclonal antibody against
early endosome antigen 1 (EEA-1; BD Biosciences
Pharmingen), CY3-conjugated goat F(ab′)2 fragments of
anti-mouse immunoglobulin G (IgG; Molecular Probes,
Eugene, OR), CY3-conjugated goat F(ab′)2 fragments of
anti-rabbit IgG (Jackson InmunoResearch, West Grove,
PA), and FITC-conjugated goat F(ab′)2 fragments of
anti-rabbit IgG (Jackson InmunoResearch). Polyclonal rab-
bit anti-B. pertussis antiserum was obtained as described
elsewhere (Hellwig et al., 2001).
Cells and growth conditions
The human alveolar epithelium cell line A549 (human lung
type-II pneumocyte; American Type Culture Collection
CCL185, Rockville, MD) was cultured in 10% fetal bovine
serum (FBS; DMEM): Dulbecco’s modified Eagle’s
Minimal Essential Medium (DMEM) supplemented with
10% (v/v) FBS, 100 U mL1 penicillin, and 100 mg mL1
streptomycin (Sigma, St. Louis, MO) at 37 °C in 5% (v/v)
CO2. Routine subcultures for A549 pneumocytes were
performed at 1 : 3 split ratios by incubation with 0.05%
(w/v) trypsin plus 0.02% (w/v) ethylenediaminetetraacetic
acid for 5 min at 37 °C. For infection assays, the epithelial
cells were cultured to 70% confluence.
Infection assays
Infection assays were performed as described in the study
by Lamberti et al. (2009), with minor modifications. Stated in
brief, A549 cells were seeded on glass coverslips in 24-well
tissue culture plates (Nunc, Roskilde, Denmark) and
cultured to 70% confluence. The monolayers were then
washed twice with sterile phosphate-buffered saline (PBS)
and infected with either B. pertussis or GFP-B. pertussis in
0.2% bovine serum albumin (BSA; DMEM): DMEM plus
0.2% (w/v) BSA (Sigma) at a multiplicity of infection (MOI) of
150 bacteria per cell unless otherwise stated. To facilitate
bacterial interaction with the epithelial cells, the plates were
centrifuged for 5 min at 640 g. After 2 h at 37 °C in 5% (v/v)
CO2, the infected cells were washed four times with PBS to
remove nonadherent bacteria. For the determination of
bacterial attachment, the cells were fixed with 3% (v/v)
paraformaldehyde. The number of adherent GFP-bacteria
per cell was then determined by microscopical examination
of 20 randomly selected fields. In representative samples,
the viability of adherent bacteria was evaluated by means of
the LIVE/DEAD BacLight kit (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions. For invasion
assays, after the washing steps, the cells were incubated
for another 12 h at 37 °C in 0.2% BSA (DMEM) unless
otherwise stated. The number of intracellular bacteria was
finally determined both by double staining immunofluores-
cence microscopy and by polymyxin B protection assays as
described below.
For immunofluorescence staining of intracellular and
extracellular bacteria, surface-bound bacteria were detected
by incubation of the A549 cells with rabbit anti-B. pertussis
serum for 1 h at 4 °C, followed by incubation with CY3-con-
jugated goat F(ab′)2 fragments of anti-rabbit IgG for another
1 h at 4 °C. To determine the number of intracellular
bacteria, after two washes of the cultures with 0.2% BSA
(PBS), the cells were permeabilized by incubation with PBS
containing 0.1% (w/v) saponin (Sigma) and 0.2% (w/v) BSA
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for 30 min, followed by a further incubation for 1 h at 4 °C
with rabbit anti-B. pertussis serum in the presence of 0.1%
(w/v) saponin and 0.2% (w/v) BSA. After three further
washes, the cells were incubated with FITC-conjugated F
(ab′)2 fragments of goat anti-rabbit IgG for 1 h at 4 °C. The
labeling of intracellular bacteria with FITC-conjugated anti-
bodies was performed to minimize the loss of readout
sensitivity resulting from the quenching of GFP fluorescence
after internalization. After washing, samples were analyzed
by fluorescence microscopy under a confocal laser scanning
microscope (model TCS SP5; Leica, Wetzlar, Germany).
The number of extracellular (red and green) and intracellular
(green) bacteria was evaluated by examination of at least
100 eukaryotic cells.
For the polymyxin B protection assays, cells were
incubated for 1 h at 37 °C in 10% FBS (DMEM)
supplemented with 100 lg mL1 of polymyxin B sulfate
(Sigma) – an antibiotic that cannot penetrate mammalian
cells (Lee et al., 1990) – to kill the remaining extracellular
bacteria. After three washing steps, infected monolayers
of the A549 cells were incubated with trypsin to detach
the cells from the well, and the number of viable
eukaryotic cells was determined by trypan blue dye
exclusion. Next, the cells were lysed with 0.1% (w/v)
saponin in sterile water, and serial dilutions of the lysates
were rapidly plated onto bBGA plates to enumerate
colony-forming units (CFU). Viable intracellular bacteria
were expressed as the number of viable bacteria per
A549 cell. Control experiments to assess the efficacy of
antibiotic bactericidal activity were performed in parallel,
as stated here in brief: Samples of 5 9 108 bacteria were
incubated with polymyxin B in 10% FBS (DMEM) for 1 h
at 37 °C and then plated on bBGA. This antibiotic
exposure resulted in a 99.999% decrease in CFU.
When indicated, cells were preincubated for 1 h with
cytochalasin D (5 lg mL1), nocodazole (10 lM), or
genistein (100 lM). The drugs (purchased from Sigma)
were maintained throughout the experiment. In separate
experiments, cells were pretreated with 10 mM
methyl-ß-cyclodextrin (MßCD; Sigma) plus 5 lg mL1 of
lovastatin (Sigma) for 15 min at 37 °C as described previ-
ously (Lamberti et al., 2009) before infection with B. per-
tussis. In these experiments, lovastatin (5 lg mL1) was
maintained throughout the infection period. At the concen-
trations used, none of the treatments affected epithelial cell
viability as determined by trypan blue dye exclusion.
Moreover, the drugs did not affect bacterial viability or
growth rate under the conditions tested.
To determine intracellular viability over time, in selected
experiments after polymyxin B (100 lg mL1) treatment,
the cells were washed to remove the antibiotic and further
incubated with 10% FBS (DMEM), 1% FBS (DMEM), or
0.2% BSA (DMEM), with or without the addition of polymyxin
B (5 lg mL1), for a further 0, 24, and 48 h. The viable
intracellular bacteria per epithelial cell were then determined
by CFU counts as described above. Informative control
experiments demonstrated that polymyxin B treatment did
not affect A549 cell viability over the time of the experiment,
as determined by trypan blue dye exclusion. Likewise,
additional controls demonstrated that bacterial infection did
not induce A549 cell lysis as compared to uninfected cells
during the experiment, as determined by trypan blue dye
exclusion.
Confocal laser scanning microscopy analysis
A549 cells were seeded onto glass coverslips. For studies
of bacterial colocalization with filamentous actin, the cells
were infected for 2 h with B. pertussis (MOI 150),
washed, and incubated for a further 12 h at 37 °C. For
F-actin labeling, the cells were then fixed with 3%
paraformaldehyde at room temperature for 15 min and
incubated with FITC-conjugated phalloidin (Sigma) diluted
1 : 100. To label B. pertussis, the cells were first per-
meabilized by incubation with PBS containing 0.1%
saponin and 0.2% BSA for 30 min and then incubated
for 1 h with rabbit anti-B. pertussis serum in the presence
of 0.1% saponin and 0.2% BSA. After three washes, the
cells were incubated for 1 h at 4 °C with CY3-conjugated
F(ab′)2 fragments of goat anti-rabbit IgG in the presence
of 0.1% saponin and 0.2% BSA, washed, and analyzed by
confocal microscopy as described below.
For colocalization studies of bacteria with the LAMP1,
the EEA1, or the LysoTrackerTM probe, A549 cells were
infected for 2 h with B. pertussis at an MOI of 150 unless
otherwise stated, washed, and incubated for a further
12 h at 37 °C. Extracellular bacteria were then killed with
polymyxin B (100 lg mL1) as described above, and the
cells were further incubated in 10% FBS (DMEM)
containing 5 lg mL1 of polymyxin B for 0, 24, and
48 h. The cells were finally incubated with or without
200 nM LysoTrackerTM DND-99 (Molecular Probes) for
5 min at 37 °C before fixation with paraformaldehyde.
Those samples that were not incubated with the Lyso-
TrackerTM stain were washed twice with PBS and incu-
bated for 10 min at room temperature with PBS containing
50 mM NH4Cl. After two washes, cells were incubated for
30 min with PBS containing 0.1% saponin and 0.2% BSA.
Next, the cells were incubated for 1 h at 4 °C with either
mouse anti-human LAMP-1 monoclonal antibodies plus
rabbit anti-B. pertussis serum or FITC-conjugated mouse
anti-human EEA1 monoclonal antibodies plus rabbit
anti-B. pertussis serum in the presence of 0.1% saponin
and 0.2% BSA. The cells were then washed three times
with 0.1% saponin and 0.2% BSA. For colocalization
studies with LAMP1, the cells were incubated (1 h) with
FITC-conjugated F(ab′)2 fragments of goat anti-rabbit IgG
and CY3-conjugated F(ab′)2 fragments of goat anti-mouse
IgG (1 h at 4 °C). For colocalization studies with EEA1,
the cells were incubated with CY3-conjugated F(ab′)2
fragments of goat anti-rabbit IgG. Isotype controls were
run in parallel. To avoid cytophilic binding of antibodies to
FccR, all incubations were performed in the presence of
25% (v/v) heat-inactivated human serum.
Microscopical analyses were performed with a confocal
laser scanning microscope (model TCS SP5; Leica). In all
experiments, a minimum of 100 eukaryotic cells were
examined per sample.
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Statistical analysis
The Student’s t-test (confidence level, 95%) or ANOVA was
used for statistical evaluation of the data. The significance of
the differences between the mean values of the data as
evaluated by ANOVA was determined by means of the least
significant difference test at a confidence level of 95%. The
results are shown as means  SD.
Results
Entry of B. pertussis into A549 cells
The ability of B. pertussis to invade A549 cells and survive
intracellularly was evaluated through the use of polymyxin B
protection assays. To that end, B. pertussis was incubated
with the epithelial cells at an MOI of 150 for 2 h at 37 °C,
washed to remove nonadherent bacteria, and further
incubated for 0, 3, 12, or 24 h before polymyxin B treatment.
The number of viable intracellular bacteria was quantified
by CFU counts. Figure 1 shows an increase in the number
of viable intracellular bacteria as the incubation time
progressed, indicating that after initial attachment, the entry
of the bacteria proceeded for at least 24 h. Double
fluorescence staining of intracellular and extracellular
bacteria further revealed that more than 90% of the
epithelial cells were infected (data not shown). The invasion
rates at lower MOIs (100, 50, and 10 bacteria per cell) were
also tested. As expected, at lower MOIs, a decrease in
the initial bacterial attachment occurred along with a
concomitant reduction in the number of viable intracellular
B. pertussis. At an MOI as low as 10, however, after 2 h of
infection, a significant number of viable bacteria were
already detected in the cells (10  4 bacteria per 100 cells).
To have a number of intracellular bacteria that enabled a
proper readout, subsequent studies were carried out at an
MOI of 150 with the infection proceeding for 12 h at 37 °C
unless otherwise stated.
Involvement of host microtubular network, lipid raft
domains, and tyrosine kinase activity in the entry of
B. pertussis into A549 cells
Bacterial entry usually requires host cytoskeleton rear-
rangements (Alonso & Garcia-del Portillo, 2004) and
normally involves microfilaments (Dramsi & Cossart,
1998; Chu & Lu, 2005) or microtubules alone (Oelschlae-
ger et al., 1993; Morey et al., 2011) or both microfila-
ments and microtubules (Richardson & Sadoff, 1988;
Tsuda et al., 2005; Dhakal & Mulvey, 2009). To determine
the contribution of microfilaments during B. pertussis
invasion, the spatial association of B. pertussis with the
actin of the host cytoskeleton was analyzed by confocal
microscopy after 12 h of infection. Figure 2 shows
F-actin-rich structures colocalizing with adherent bacteria
(Fig. 2, surface focal plane). In contrast to the adherence-
associated rearrangement of actin, intracellular bacteria
were not associated with the host filamentous actin
(Fig. 2, middle focal plane). To further evaluate the role
of actin polymerization in B. pertussis entry, we preincu-
bated A549 cells with cytochalasin D, an inhibitor of actin
polymerization that disrupts microfilaments, and then
determined bacterial internalization by the polymyxin B
protection assay. Treatment of A549 cells with cytocha-
lasin D did not decrease the number of intracellular
bacteria (Fig. 3), indicating that the observed mobilization
of F-actin around adhering B. pertussis is not implicated in
the bacterial entry into A549 cells. We then evaluated
whether microtubular polymerization might be involved in
B. pertussis invasion. To this end, before infection, the
A549 cells were treated with nocodazole, a microtu-
bule-depolymerizing agent, and upon infection, bacterial
invasion was once again determined by the polymyxin B
protection assay. Bordetella pertussis entry decreased by
approximately 62% upon the addition of nocodazole
(Fig. 3), suggesting that B. pertussis entry involves the
assembly of the host microtubular network. That noco-
dazole affected neither bacterial attachment to A549 cells
nor cell viability, as determined by trypan blue staining
(data not shown), ruled out those possible trivial explana-
tions.
A previous report had shown that lipid rafts localized
around adhering B. pertussis during attachment (Lamberti
et al., 2009). These domains were later found to be involved
in the invasion by and intracellular survival of other bacterial
pathogens (Hartlova et al., 2010). To investigate more
precisely the role of lipid rafts in the entry of B. pertussis
into epithelial cells, A549 cells were incubated with MßCD –
a compound that disrupts cholesterol-rich domains by
extracting the sterol – and then examined for bacterial
attachment at 2 h and bacterial invasion at 12 h postinfec-
tion. The experiments were performed in the presence of
lovastatin to inhibit de novo cholesterol synthesis. The
number of intracellular bacteria was determined by fluores-
cent staining of extra- and intracellular bacteria in combina-
tion with the polymyxin B protection assay. Figure 4(a)
shows representative images of the epithelial cells incu-
bated with or without MßCD before infection. In agreement
Fig. 1 Kinetics of entry of Bordetella pertussis into epithelial cells. A549
cells were infected with B. pertussis (MOI 150) during 2 h, washed to
remove nonadherent bacteria, and further incubated for other 0, 3, 12, or
24 h. The number of viable intracellular B. pertussis at the various time
points was determined by the polymyxin B protection assay. The data
represent the mean  SD of two independent experiments performed in
triplicate.
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with previous results (Lamberti et al., 2009), the attachment
of B. pertussis to the epithelial cells was significantly
diminished by MßCD treatment of the cells: A 60  4%
reduction in bacterial adherence was observed in
MßCD-treated cells as compared with untreated controls.
To evaluate the effect of MßCD on B. pertussis entry
independently of the reduction in bacterial attachment, the
extent of bacterial internalization was calculated as a
percentage of the number of surface-associated bacteria
determined at 2 h postinfection. Figure 4(b) shows that
cholesterol depletion led to a significant decrease in
bacterial entry, indicating that apart from bacterial attach-
ment, lipid rafts are involved in the entry of B. pertussis. A
similar reduction in the number of viable intracellular
bacteria was observed in the polymyxin B protection assays
(data not shown).
We next studied the contribution of tyrosine kinases to
B. pertussis entry into the pulmonary epithelial cells.
Tyrosine kinases had been found to be crucial for the
lipid raft-dependent invasion processes of other pathogens
(Zaas et al., 2005b; Schulz et al., 2012). Accordingly,
A549 cells were treated with genistein – a tyrosine kinase
inhibitor generally recognized as a selective blocker of
raft-dependent endocytic pathways (Lajoie & Nabi, 2007)
– and B. pertussis invasion was subsequently determined
by the polymyxin B protection assay. Treatment of A549
cells with this drug did not affect the bacterial attachment
level (data not shown) but significantly decreased the
number of intracellular B. pertussis (Fig. 5), suggesting
that tyrosine kinase activity might participate in the
dependence of bacterial entry on lipid rafts.
Bordetella pertussis survival and trafficking inside
A549 cells
Host cell invasion and intracellular survival is an effective
immune evasion strategy for many pathogenic bacteria
(Haglund & Welch, 2011). We therefore evaluated the
intracellular fate of B. pertussis after entering into the
respiratory epithelial cells. To this end, A549 cells were
Fig. 2 Confocal microscopy analysis of Bordetella pertussis association with host actin cytoskeleton. A549 cells were infected with B. pertussis at an
MOI of 150 for 2 h at 37 °C, washed, and incubated for a further 12 h. Samples were fixed and stained for F-actin (green) and B. pertussis (red).
Images were obtained in various focal planes by scanning from the apical to the basal surfaces of the eukaryotic cell. Confocal images of a surface
focal plane and a middle focal plane of the same cell are shown. The colocalization of adherent bacteria and actin filament is indicated by arrows. The
lack of colocalization of intracellular bacteria and actin filament is indicated by arrowheads. Representatives of one of three independent experiments
are shown.
Fig. 3 Requirement of host cell microtubule polymerization for
Bordetella pertussis invasion. A549 cells treated without inhibitors
(control) or with cytochalasin D (5 lg mL1) or nocodazole (10 lM) for
1 h at 37 °C were incubated with B. pertussis (MOI 150) for 2 h at
37 °C, washed, and incubated for a further 12 h in the presence of the
respective drug. The number of live intracellular bacteria was
determined by the polymyxin B protection assay. The figure shows the
mean values  SD of two independent experiments each performed in
triplicate. The number of viable intracellular bacteria in nocodaz-
ole-treated cells was significantly different from the number of viable
intracellular bacteria in nontreated or cytochalasin D-treated cells
(*P < 0.05).
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infected with B. pertussis for 12 h and further treated with
polymyxin B to kill extracellular bacteria. The cells were
incubated for an additional 0, 24, or 48 h in the presence of
polymyxin B (5 lg mL1). The number of viable intracellular
bacteria was evaluated at different times by CFU counts. To
estimate the percentage of intracellular B. pertussis that
were able to survive, the number of bacteria inside the cells
was determined in parallel by two-color fluorescence
microscopy, which enabled the discrimination between
extra- and intracellular bacteria. Figure 6(a) shows that
immediately after polymyxin B treatment (time = 0 h),
3.82  0.55 bacteria per cell were alive (48  9% of the
intracellular bacteria). Importantly, about 100% of the
bacteria associated with the epithelial cells had been alive
before polymyxin B treatment, as determined by live–dead
differential staining (data not shown). To investigate the
subcellular localization of the internalized B. pertussis, A549
cells were stained with the late endosomal/lysosomal
marker LAMP1. Figure 6(b) shows that 54  7% of the
intracellular bacteria were found in LAMP1-negative phago-
somes immediately after polymyxin B treatment (Fig. 6b,
0 h). As time progressed, the number of viable intracellular
bacteria decreased (Fig. 6a), while the number of B. pertus-
sis-containing phagosomes positive for LAMP1 increased
(Fig. 6b and c). At 24 h after polymyxin B treatment, c. 28%
of the intracellular bacteria (1.57  0.36 of 5.63  0.6
bacteria) were found not colocalized with LAMP1 label,
and at that time, the CFU counts indicated a total of
1.4  0.18 viable bacteria per cell. A similar correspon-
dence between the number of LAMP1-negative bacteria and
CFU counts was observed in samples taken at 48 h (Fig. 6).
Colocalization studies with LysoTrackerTM, an acidotropic
fluorescent dye that accumulates in acidic organelles,
showed similar results. A lack of colocalization of B. per-
tussis with LysoTrackerTM was observed in 3.6  0.6,
1.5  0.4, and 0.7  0.3 bacteria per cell at 0, 24, and
48 h, respectively, after polymyxin B treatment. To further
investigate the intracellular localization of the bacteria that
were not found within late endosomal or lysosomal com-
partments, A549 cells were stained with the early endoso-
mal marker EEA1. Colocalization studies indicated that
about 20% of the intracellular B. pertussis were located in
EEA1-positive compartments 48 h after polymyxin B treat-
ment (Fig. 7).
Relevant too is the observation that this intracellular
trafficking was also observed in assays performed at the
lowest MOI tested (an MOI of 10; data not shown).
(a)
(b)
A B
Fig. 4 Involvement of cholesterol-rich domains in Bordetella pertussis
attachment to and entry into A549 cells. A549 cells incubated without
(control) or with 10 mM of MßCD (15 min at 37 °C) were infected with
GFP-B. pertussis (MOI 150) in the presence of lovastatin (5 lg mL1).
After 2 h, the cells were either washed, fixed, and processed for the
determination of bacterial attachment or incubated for a further 12 h in
the presence of lovastatin (5 lg mL1) before determination of both
surface-bound and intracellular bacteria by two-color immune fluores-
cence. (a) Representative images showing extracellular (yellow) and
intracellular (green) bacteria in control (A) and MßCD-treated cells (B)
12 h postinfection. (b) Bacterial internalization. The number of intracel-
lular bacteria 12 h after attachment was expressed as a percentage of
the number of adherent bacteria at 2 h postinfection. The data represent
the mean  SD of two independent experiments each performed in
triplicate. The percentage of bacteria internalized by MßCD-treated cells
was significantly different from the corresponding percentage internal-
ized by untreated cells (control; *P < 0.05).
Fig. 5 Dependence of Bordetella pertussis entry into A549 cells on
tyrosine kinase activity. A549 cells incubated without (control) or with
100 lM genistein (1 h at 37 °C) were infected with GFP-B. pertussis
(MOI 150). After 2 h, the cells were washed and incubated for a further
12 h in the presence of genistein. The presence of live intracellular
bacteria was determined by the polymyxin B protection assay. The data
represent the mean  SD of two independent experiments each
performed in triplicate. The number of viable intracellular bacteria in
genistein-treated cells was significantly different from the number of
viable intracellular bacteria in the untreated controls (*P < 0.05).
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Release of viable intracellular B. pertussis from the
cells into the medium
Because both cell entry and exit are critical steps in the cell
cycles of intracellular pathogens (Hybiske & Stephens,
2007), we next examined whether intracellular B. pertussis
was released in a viable state into the extracellular medium.
To investigate this question, epithelial cell infection was
carried out as described above, but after the initial killing of
the extracellular bacteria with polymyxin B (100 lg mL1),
cells were incubated with either 10% FBS (DMEM) plus
polymyxin B (5 lg mL1) or the same medium without the
antibiotic for 48 h. Control experiments verified that B. per-
tussis remained alive in 10% FBS (DMEM), but not in 10%
(a) (b)
(c)
Fig. 6 Survival of Bordetella pertussis inside A549 cells in LAMP1-negative compartments. (a) Intracellular survival. A549 cells were infected with
B. pertussis (MOI 150) for 2 h, washed to remove nonadherent bacteria, and incubated for a further 12 h. The cells were then treated with polymyxin B
(100 lg mL1) for 1 h at 37 °C, washed, and incubated for an additional 0, 24, or 48 h in the presence of polymyxin B (5 lg mL1). The number of
viable intracellular bacteria was evaluated at different times by CFU counts. The data represent the mean  SD of four independent experiments each
performed in triplicate. (b) Colocalization of B. pertussis and LAMP1. A549 cells were infected with GFP-B. pertussis (MOI 150) for 2 h, washed, and
incubated for a further 12 h. Cells were then treated for 1 h with polymyxin B (100 lg mL1) and incubated for an additional 0, 24, or 48 h in the
presence of the antibiotic. At the different time points, cells were fixed and permeabilized before incubation with antibodies against LAMP1 (red) and
against B. pertussis (green). The bars indicate the number of LAMP1-positive (gray) or LAMP1-negative (black) phagosomes per cell. The data
represent the mean of three independent experiments each performed in triplicate. (c) Representative confocal images showing colocalization of
B. pertussis with LAMP1 at 48 h after polymyxin B treatment. Arrows indicate LAMP1-positive B. pertussis compartments.
Fig. 7 Colocalization of Bordetella pertussis with early endosomal markers. A549 cells were infected with B. pertussis (MOI 150) during 2 h, washed,
and incubated for other 12 h in 0.2% BSA (DMEM). Cells were then treated for 1 h with polymyxin B (100 lg mL1) and incubated for another 48 h in
the presence of antibiotics. At 0, 24, and 48 h, the cells were fixed and permeabilized prior to incubation with antibodies against EEA1 (green) and
against B. pertussis (red). The bars indicate percentages of EEA1-positive phagosomes. The data represent the mean  SD of three independent
experiments. Representative confocal microscopy images of the colocalization of B. pertussis with EEA1 48 h after polymyxin B treatment are shown.
Arrows indicate EEA1-positive B. pertussis compartments.
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FBS (DMEM) plus polymyxin B (5 lg mL1), indicating that
the intracellular bacteria released into the medium would be
able to survive only in the antibiotic-free medium. Samples
were taken at 0, 24, and 48 h after initial polymyxin B
treatment. The number of viable bacteria either cell-asso-
ciated or free in the medium was determined under each
condition tested (Fig. 8a and b, respectively). In samples
taken at 24 and 48 h, a significantly higher number of viable
bacteria both associated with the cell and free in the medium
were found in the assays performed without antibiotics as
compared with those containing antibiotics. These results
suggested that intracellular B. pertussis was released in a
viable state into the surrounding medium. Similar results
were obtained in experiments carried out in 0.2% BSA
(DMEM) or 1% FBS (DMEM); and because both of those
media limited A549 cell growth during the 48-h infection
period, the exiting from the cell by B. pertussis was very
likely not associated with cell lysis as a consequence of
culture overgrowth (data not shown).
Discussion
Bacterial pathogens are often divided into the categories of
intracellular and extracellular microorganisms in accordance
with their capacity to invade and survive within host cells.
This division, however, has become increasingly blurred as
more and more pathogens referred to historically as extra-
cellular were found to have alternative intracellular lifestyles
(Petersen & Krogfelt, 2003; Bower et al., 2005; Morey et al.,
2011). In the example of B. pertussis, an increasing number
of reports based on infection assays in cultured cells
(Ewanowich et al., 1989; Friedman et al., 1992; Masure,
1993; Gueirard et al., 2005; Lamberti et al., 2008, 2010)
and examination of biopsies (Bromberg et al., 1991; Hellwig
et al., 1999; Paddock et al., 2008) have suggested that
these bacteria are capable of invading many cell types.
Recent research has further indicated that B. pertussis is
able to evade intracellular killing (Lamberti et al., 2008,
2010). In particular, the bacterium has been demonstrated
to be able to survive the encounter with immune cells so as
to remain viable in nonacidic compartments with access to
the recycling pathways (Lamberti et al., 2008, 2010).
Moreover, B. pertussis seems able to replicate inside these
compartments, suggesting that the species might be
considered a facultative intracellular bacterium (Lamberti
et al., 2010).
In the present study, we investigated the interaction of
B. pertussis with respiratory epithelial cells, another relevant
cell type at the site of infection. Several pathogens acquired
through inhalation can invade respiratory epithelial cells,
including Mycoplasma pneumoniae (Yavlovich et al., 2004),
Burkholderia cepacia (Martin & Mohr, 2000), and Haemo-
philus influenza (Morey et al., 2011). Most of these invasive
microorganisms, although not all, are also capable of
intracellular replication. In the instance of B. pertussis, a
number of studies, with both primary cell cultures and
established cell lines, have suggested that this pathogen is
able to invade epithelial cells (Higgs et al., 2012). The
molecular mechanisms underlying this process and the
intracellular fate of B. pertussis, however, have still
remained unknown. The present study shows that the entry
of B. pertussis into respiratory epithelial cells requires
microtubule assembly, lipid raft integrity, and the activation
of tyrosine kinases. Once inside the cell, a significant
proportion of the bacteria evade lysosomal fusion and
remain viable for several days.
We have previously shown that lipid raft domains act as
platforms that cluster molecules susceptible to FHA ligation
(a) (b)
Fig. 8 Release of viable intracellular bacteria into the medium. A549 cells were infected with Bordetella pertussis at an MOI of 150 for 2 h at 37 °C,
washed, and incubated for a further 12 h. Cells were then treated with polymyxin B (100 lg mL1) for 1 h at 37 °C, washed, and incubated in 10%
FBS (DMEM) with (gray) or without (black) polymyxin B (5 lg mL1) for an additional 0, 24, or 48 h. At the indicated time points, the number of viable
bacteria associated with the cell (a) and free in the medium (b) was determined. (a) Bacteria associated with A549 cells. Cells were detached by trypsin
treatment and the number of bacteria per cell determined by CFU counts. The data represent the mean  SD of three independent experiments each
performed in triplicate. (b) Free extracellular bacteria. The number of extracellular cell-free bacteria was determined by sampling the medium for CFU
counts. The data represent the mean  SD of three independent experiments performed in triplicate.
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and in that manner contribute to effective B. pertussis
binding to A549 cells (Lamberti et al., 2009). These domains
have been shown to be involved in cellular invasion by many
pathogens (Lafont & van der Goot, 2005; Hartlova et al.,
2010) and appear to provide the signaling platforms required
for bacterial entry (Lafont & van der Goot, 2005; Zaas et al.,
2005a). In the present experiments, we found that lipid rafts
are involved in the entry of B. pertussis into respiratory
epithelial cells. Accordingly, treatment of A549 cells with the
lipid raft–disrupting drug MßCD decreased B. pertussis
invasion to a greater extent than the reduction observed in
attachment, suggesting that these domains not only serve
as platforms that facilitate B. pertussis binding to the host
cell, but also mediate the entry of the pathogen. Indeed,
invasion by B. pertussis was significantly impaired in the
presence of genistein, a selective inhibitor of tyro-
sine-kinase-mediated and lipid raft-dependent endocytic
pathways (Lajoie & Nabi, 2007), suggesting that tyrosine
kinase activity is involved in B. pertussis internalization
through lipid raft domains.
Lipid raft–dependent endocytosis may proceed through
microtubule- and/or actin-dependent pathways (Lajoie &
Nabi, 2007). Whereas actin microfilaments are frequently
associated with the bacterial invasion process, a small
number of pathogens need the polymerization of the host
microtubule network to invade (Yoshida & Sasakawa, 2003).
Bordetella pertussis seems to belong to this latter group of
pathogens. Treatment of A549 cells with nocodazole, a
microtubule-depolymerizing agent, significantly reduced the
number of internalized bacteria. In contrast, actin–cytoskel-
eton depolymerization by cytochalasin D did not affect
invasion by B. pertussis. Accordingly, intracellular B. per-
tussis was never found associated with condensed actin
filaments.
Bordetella pertussis FHA plays a major role in adherence
to epithelial cells (Perez Vidakovics et al., 2006). FHA has
been suggested as possibly promoting the invasion of
human respiratory epithelial cells through the interaction of
the bacterial arginine–glycine–aspartate (RGD) sequence
with the host cell a5ß1 integrin (Ishibashi et al., 2001). Like
B. pertussis, several microbial pathogens exploit integrins
and the latter’s endocytotic capacity to invade nonphagocytic
cells (Guignot et al., 2001; Tsuda et al., 2008; Krause-Gru-
szczynska et al., 2011; Lopez-Gomez et al., 2012). The
invasin of Yersinia enterocolitica has been demonstrated to
involve the binding of the a5ß1 integrins on eukaryotic cells in
order to promote internalization via a receptor-mediated
mechanism that, for its part, involves protein tyrosine kinase
signaling (Isberg et al., 2000). These kinases are usually the
orchestrators of a linkage between the integrins and signal
transduction, with the lipid raft domains playing a key role in
this interaction (Leitinger & Hogg, 2002; Mitchell et al., 2002;
Gagnoux-Palacios et al., 2003; del Pozo et al., 2004; Upla
et al., 2004; van Zanten et al., 2009). That lipid rafts and
a5ß1 integrins participate in B. pertussis entry into epithelial
cells suggests a spatial and functional link between raft and
integrins during B. pertussis entry.
A strategy used by several pathogens for survival in the
hostile host environment is to hide within the mammalian
cells. The mechanisms by which pathogens resist intracel-
lular killing include inhibition of phagosome–lysosome
fusion, escape into the cytoplasmic compartment, and
resistance to the harsh environment of the lysosome
(Moulder, 1985). To investigate the fate of B. pertussis
inside respiratory cells, CFU counts and trafficking studies
were conducted in parallel. We examined the association of
B. pertussis with acidic (LysoTrackerTM-positive) vacuoles
and LAMP1- and EEA-1-containing vacuoles. Our overall
data suggest that part of the internalized bacteria manage to
avoid the lysosomal degradation pathway. We accordingly
found a correlation between the number of viable intracel-
lular bacteria and the number of either LAMP1-negative,
LysoTrackerTM-negative, or EEA-1-positive bacteria per cell,
suggesting that those bacteria had survived through escape
from the lysosomal pathway and remain in EEA-1-positive
compartments. These results are in agreement with previ-
ous reports indicating that B. pertussis is able to survive
within nonacidic compartments in human macrophages
(Lamberti et al., 2010).
Although we cannot rule out the possibility, under our
experimental conditions, we did not detect bacterial replica-
tion inside A549 cells. A similar behavior had been found
with other pathogens, such as Campylobacter jejuni (Wat-
son & Galan, 2008), B. cepacia (Lamothe et al., 2004), and
Salmonella enteric (Cano et al., 2001), all of which bacteria
produce long-lasting infections inside host cells in the
absence of proliferation.
Intracellular survival may provide substantial advantages
for bacterial persistence within the host. Apart from
protecting the pathogen from the host immunity defenses,
the intracellular location detected here might provide
protection against antibacterial treatments or local inflam-
mation during infection. Similar to what was described for
other pathogens (Osterlund & Engstrand, 1995; Dubois &
Boren, 2007), B. pertussis might reside dormant inside
host cells and egress once the extracellular environment
became permissive. In this study, we found evidence that
intracellular B. pertussis is able to repopulate the extra-
cellular environment, with the implication that B. pertussis
is released viable into the extracellular medium. These
results suggest that the intracellular survival within the
respiratory epithelium might contribute to the persistence
of B. pertussis within the host.
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